Fujian, China

Shiye Shen

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biosteed Gene Expression Tech. Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shiye Shen. Retrieved from https://idiyas.com/inventor/shiye-shen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shiye Shen: Innovator in Growth Hormone Modification

Introduction

Shiye Shen is a notable inventor based in Fujian, China. He has made significant contributions to the field of biotechnology, particularly in the modification of growth hormones. His innovative work has implications for treating various growth disorders.

Latest Patents

Shiye Shen holds a patent for a "Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof." This invention involves a growth hormone that has been modified with double-stranded polyethylene glycol at a single site. The PEGylated growth hormone exhibits higher biological activity and a longer half-life compared to unmodified growth hormone. This composition is particularly useful in treating growth or development disorders, such as growth hormone deficiency and Turner syndrome.

Career Highlights

Shiye Shen is associated with Biosteed Gene Expression Tech Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve therapeutic outcomes for patients with growth-related issues.

Collaborations

Shiye Shen collaborates with esteemed colleagues, including Weidong Zhou and Xiaojin Liao, who contribute to his research endeavors and help drive innovation in the field.

Conclusion

Shiye Shen's contributions to the modification of growth hormones represent a significant advancement in biotechnology. His innovative approach has the potential to enhance treatment options for individuals with growth disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…